MUMBAI (Reuters) - Drug manufacturer Alkem Laboratories Ltd is set to launch an initial public offering (IPO) worth nearly $210 million in the second week of December, three sources directly involved in the transaction said on Tuesday.
Alkem Labs' share sale will be India's third high-profile market debut in the last three months of 2015, after airline IndiGo raised $459 million and Coffee Day Enterprises raised $176 million.
The company had filed a draft prospectus with India's capital markets regulator in August for an IPO of up to 12.85 million equity shares, constituting 10.75 percent of the paid-up capital.
Officials at Alkem Labs were not immediately reachable for comment.
Spokespeople for Nomura, Axis Capital, JP Morgan and Edelweiss, the bankers on the deal, did not immediately respond to requests for comment.
($1 = 65.4300 rupees)
(Reporting by Abhishek Vishnoi and Clara Ferreira Marques; Editing by Rafael Nam)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app